Effect of Hyperglycemia and Insulin in Acute Coronary Syndromes

American Journal of Cardiology

Volumn 99, Issue 11 SUPPL., 2007, Pages

  Dandona, Paresh ^a   Chaudhuri, Ajay ^a   Ghanim, Husam ^a   Mohanty, Priya ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; FATTY ACID; GELATINASE A; GELATINASE B; GLUCOSE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POTASSIUM; PROTEIN P47; REACTIVE OXYGEN METABOLITE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; DRUG INFUSION; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INTENSIVE CARE; LOW DRUG DOSE; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROKE;

BLOOD GLUCOSE; CLINICAL TRIALS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MYOCARDIAL INFARCTION;

EID: 34249692447     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.04.004     Document Type: Article

References (75)

1. Dandona P., Mohanty P., Chaudhuri A., Garg R., and Aljada A. Insulin infusion in acute illness. J Clin Invest 115 (2005) 2069-2072
2. Chaudhuri A., Janicke D., Wilson M.F., Tripathy D., Garg R., Bandyopadhyay A., Calieri J., Hoffmeyer D., Syed T., Ghanim H., Aljada A., and Dandona P. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109 (2004) 849-854
3. Mohanty P., Hamouda W., Garg R., Aljada A., Ghanim H., and Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85 (2000) 2970-2973
4. Aljada A., Ghanim H., Mohanty P., Syed T., Bandyopadhyay A., and Dandona P. Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr 80 (2004) 51-57
5. Dhindsa S., Tripathy D., Mohanty P., Ghanim H., Syed T., Aljada A., and Dandona P. Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-κB in mononuclear cells. Metabolism 53 (2004) 330-334
6. Ghanim H., Aljada A., Hofmeyer D., Syed T., Mohanty P., and Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110 (2004) 1564-1571
7. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., Quagliaro L., Ceriello A., and Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 (2002) 2067-2072
8. Tripathy D., Mohanty P., Dhindsa S., Syed T., Ghanim H., Aljada A., and Dandona P. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52 (2003) 2882-2887
9. Itani S.I., Ruderman N.B., Schmieder F., and Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51 (2002) 2005-2011
10. Dandona P. Endothelium, inflammation, and diabetes. Curr Diab Rep 2 (2002) 311-315
11. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24 (2004) 1015-1022
12. Umpierrez G.E., Isaacs S.D., Bazargan N., You X., Thaler L.M., and Kitabchi A.E. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87 (2002) 978-982
13. Wahab N.N., Cowden E.A., Pearce N.J., Gardner M.J., Merry H., Cox J.L., and ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 40 (2002) 1748-1754
14. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
15. Capes S.E., Hunt D., Malmberg K., Pathak P., and Gerstein H.C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32 (2001) 2426-2432
16. Libby P., and Simon D.I. Inflammation and thrombosis: the clot thickens. Circulation 103 (2001) 1718-1720
17. Malouf J.F., Kanagala R., Al Atawi F.O., Rosales A.G., Davison D.E., Murali N.S., Tsang T.S., Chandrasekaran K., Ammash N.M., Friedman P.A., and Somers V.K. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol 46 (2005) 1284-1287
18. Ishida K., Kimura F., Imamaki M., Ishida A., Shimura H., Kohno H., Sakurai M., and Miyazaki M. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 29 (2006) 501-505
19. Iwakura K., Ito H., Ikushima M., Kawano S., Okamura A., Asano K., Kuroda T., Tanaka K., Masuyama T., Hori M., and Fuji K. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41 (2003) 1-7
20. Timmer J.R., Ottervanger J.P., de Boer M.J., Dambrink J.H., Hoorntje J.C., Gosselink A.T., Suryapranata H., Zijlstra F., and van't Hof A.W. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45 (2005) 999-1002
21. Corpus R.A., George P.B., House J.A., Dixon S.R., Ajluni S.C., Devlin W.H., Timmis G.C., Balasubramaniam M., and O'Neill W.W. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43 (2004) 8-14
22. 1C. Cardiovasc Revasc Med 8 (2007) 15-20
23. Grover A., Padginton C., Wilson M.F., Sung B.H., Izzo Jr. J.L., and Dandona P. Insulin attenuates norepinephrine-induced venoconstriction: an ultrasonographic study. Hypertension 25 (1995) 779-784
24. Steinberg H.O., Brechtel G., Johnson A., Fineberg N., and Baron A.D. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 94 (1994) 1172-1179
25. Zeng G., and Quon M.J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 98 (1996) 894-898
26. Aljada A., and Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism 49 (2000) 147-150
27. Trovati M., Anfossi G., Massucco P., Mattiello L., Costamagna C., Piretto V., Mularoni E., Cavalot F., Bosia A., and Ghigo D. Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3′, 5′-cyclic monophosphate and adenosine-3′, 5′-cyclic monophosphate. Diabetes 46 (1997) 742-749
28. Trovati M., Massucco P., Mattiello L., Mularoni E., Cavalot F., and Anfossi G. Insulin increases guanosine-3′,5′-cyclic monophosphate in human platelets: a mechanism involved in the insulin anti-aggregating effect. Diabetes 43 (1994) 1015-1019
29. Aljada A., Ghanim H., Saadeh R., and Dandona P. Insulin inhibits NFκB and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinol Metab 86 (2001) 450-453
30. Aljada A., Ghanim H., Mohanty P., Kapur N., and Dandona P. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 87 (2002) 1419-1422
31. Dandona P., Aljada A., Mohanty P., Ghanim H., Hamouda W., Assian E., and Ahmad S. Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J Clin Endocrinol Metab 86 (2001) 3257-3265
32. Dandona P., Aljada A., Mohanty P., Ghanim H., Bandyopadhyay A., and Chaudhuri A. Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care 26 (2003) 3310-3314
33. Weis S., Shintani S., Weber A., Kirchmair R., Wood M., Cravens A., McSharry H., Iwakura A., Yoon Y.S., Himes N., et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 113 (2004) 885-894
34. Dandona P., Thusu K., Hafeez R., Abdel-Rahman E., and Chaudhuri A. Effect of hydrocortisone on oxygen free radical generation by mononuclear cells. Metabolism 47 (1998) 788-791
35. Chaudhuri A., Janicke D., Wilson M.F., Ghanim H., Aljada A., and Dandona P. Free fatty acid suppressive and cardioprotective effect of insulin in acute myocardial infarction (AMI). Diabetes 54 suppl 1 (2005) A182 Abstract 739-P
36. Wong V.W., McLean M., Boyages S.C., and Cheung N.W. C-reactive protein levels following acute myocardial infarction: effect of insulin infusion and tight glycemic control. Diabetes Care 27 (2004) 2971-2973
37. Visser L., Zuurbier C.J., Hoek F.J., Opmeer B.C., de Jonge E., de Mol B.A., and van Wezel H.B. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth 95 (2005) 448-457
38. Koskenkari J.K., Kaukoranta P.K., Rimpilainen J., Vainionpaa V., Ohtonen P.P., Surcel H.M., Juvonen T., and Ala-Kokko T.I. Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery. Acta Anaesthesiol Scand 50 (2006) 962-969
39. Griselli M., Herbert J., Hutchinson W.L., Taylor K.M., Sohail M., Krausz T., and Pepys M.B. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 190 (1999) 1733-1740
40. Pepys M.B., Hirschfield G.M., Tennent G.A., Gallimore J.R., Kahan M.C., Bellotti V., Hawkins P.N., Myers R.M., Smith M.D., Polara A., et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440 (2006) 1217-1221
41. Langouche L., Vanhorebeek I., Vlasselaers D., Vander Perre S., Wouters P.J., Skogstrand K., Hansen T.K., and Van den Berghe G. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115 (2005) 2277-2286
42. Vanhorebeek I., De Vos R., Mesotten D., Wouters P.J., De Wolf-Peeters C., and Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
43. Herndon D.N., and Tompkins R.G. Support of the metabolic response to burn injury. Lancet 363 (2004) 1895-1902
44. Brix-Christensen V., Andersen S.K., Andersen R., Mengel A., Dyhr T., Andersen N.T., Larsson A., Schmitz O., Orskov H., and Tonnesen E. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology 100 (2004) 861-870
45. Jeschke M.G., Klein D., Bolder U., and Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145; (2004) 4084-4093
46. Jonassen A.K., Brar B.K., Mjos O.D., Sack M.N., Latchman D.S., and Yellon D.M. Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 32 (2000) 757-764
47. Jonassen A.K., Sack M.N., Mjos O.D., and Yellon D.M. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89 (2001) 1191-1198
48. Gao F., Gao E., Yue T.L., Ohlstein E.H., Lopez B.L., Christopher T.A., and Ma X.L. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105 (2002) 1497-1502
49. Tune J.D., Mallet R.T., and Downey H.F. Insulin improves contractile function during moderate ischemia in canine left ventricle. Am J Physiol 274 (1998) H1574-H1581
50. Tune J.D., Mallet R.T., and Downey H.F. Insulin improves cardiac contractile function and oxygen utilization efficiency during moderate ischemia without compromising myocardial energetics. J Mol Cell Cardiol 30 (1998) 2025-2035
51. Jeschke M.G., Einspanier R., Klein D., and Jauch K.W. Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 8 (2002) 443-450
52. Williams L.S., Rotich J., Qi R., Fineberg N., Espay A., Bruno A., Fineberg S.E., and Tierney W.R. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59 (2002) 67-71
53. Diaz R., Paolasso E.A., Piegas L.S., Tajer C.D., Moreno M.G., Corvalan R., Isea J.E., Romero G., and ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group. Metabolic modulation of acute myocardial infarction. Circulation 98 (1998) 2227-2234
54. Malmberg K., Ryden L., Efendic S., Herlitz J., Nicol P., Waldenstrom A., Wedel H., and Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
55. van der Horst I.C., Zijlstra F., van't Hof A.W., Doggen C.J., de Boer M.J., Suryapranata H., Hoorntje J.C., Dambrink J.H., Gans R.O., Bilo H.J., and Zwolle Infarct Study Group. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study. A randomized trial. J Am Coll Cardiol 42 (2003) 784-791
56. Sodi-Pallares D., Testelli M.R., Fishleder B.L., Bisteni A., Medrano G.A., Friedland C., and De Micheli A. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction: a preliminary clinical report. Am J Cardiol 9 (1962) 166-181
57. Rogers W.J., Stanley Jr. A.W., Breinig J.B., Prather J.W., McDaniel H.G., Moraski R.E., Mantle J.A., Russell Jr. R.O., and Rackley C.E. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J 92 (1976) 441-454
58. Jonassen A.K., Aasum E., Riemersma R.A., Mjos O.D., and Larsen T.S. Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther 14 (2000) 615-623
59. Zhang L., Li Y.H., Zhang H.Y., Chen M.L., Gao M.M., Hu A.H., and Yang H.S. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction. Eur J Clin Invest 35 (2005) 164-170
60. Mehta S.R., Yusuf S., Diaz R., Zhu J., Pais P., Xavier D., Paolasso E., Ahmed R., Xie C., Kazmi K., et al., CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293 (2005) 437-446
61. Malmberg K., Ryden L., Wedel H., Birkeland K., Bootsma A., Dickstein K., Efendic S., Fisher M., Hamsten A., Herlitz J., et al., DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
62. Apstein C.S., and Opie L.H. A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J 26 (2005) 956-959
63. Krljanac G., Vasiljevic Z., Radovanovic M., Stankovic G., Milic N., Stefanovic B., Kostic J., Mitrovic P., Radovanovic N., Dragovic M., Marinkovic J., and Karadzic A. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy. Am J Cardiol 96 (2005) 1053-1058
64. Cheung N.W., Wong V.W., and McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29 (2006) 765-770
65. Garg R., Chaudhuri A., Munschauer F., and Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 37 (2006) 267-273
66. Saposnik G., Young B., Silver B., Di Legge S., Webster F., Beletsky V., Jain V., Nilanont Y., and Hachinski V. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. JAMA 292 (2004) 1839-1844
67. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., and Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
68. van den Berghe G.H. Role of intravenous insulin therapy in critically ill patients. Endocr Pract 10 suppl 2 (2004) 17-20
69. van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., Van Wijngaerden E., Bobbaers H., and Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
70. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004) 992-1000
71. Furnary A.P., Gao G., Grunkemeier G.L., Wu Y., Zerr K.J., Bookin S.O., Floten H.S., and Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
72. Lazar H.L., Chipkin S.R., Fitzgerald C.A., Bao Y., Cabral H., and Apstein C.S. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109 (2004) 1497-1502
73. Lazar H.L., Philippides G., Fitzgerald C., Lancaster D., Shemin R.J., and Apstein C. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 113 (1997) 354-360 discussion 360-362
74. Quinn D.W., Pagano D., Bonser R.S., Rooney S.J., Graham T.R., Wilson I.C., Keogh B.E., Townend J.N., Lewis M.E., Nightingale P., and Study Investigators. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg 131 (2006) 34-42
75. Pan W., Hindler K., Lee V.V., Vaughn W.K., and Collard C.D. Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology 104 (2006) 441-447